Association of High-Deductible Health Plans With Health Care Use and Costs for Patients With Cardiovascular Disease.

cardiovascular disease cost sharing high‐deductible health plans out‐of‐pocket costs value‐based care

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
03 Oct 2023
Historique:
medline: 4 12 2023
pubmed: 26 9 2023
entrez: 26 9 2023
Statut: ppublish

Résumé

Background By increasing cost sharing, high-deductible health plans (HDHPs) aim to reduce low-value health care use. The association of HDHPs with health care use and costs in patients with chronic cardiovascular disease is unknown. Methods and Results This longitudinal cohort study analyzed 57 690 privately insured patients, aged 18 to 64 years, from a large commercial claims database with chronic cardiovascular disease from 2011 to 2019. Health care entities in which all or most beneficiaries switched from being in a traditional plan to an HDHP were identified. A difference-in-differences design was used to account for differences between individuals who remained in traditional plans and those who switched to HDHPs and to assess changes in health care use and costs. Among the 934 individuals in the HDHP group and the 56 756 in the traditional plan group, switching to an HDHP was not associated with statistically significant changes in annual outpatient visits, hospitalizations, or emergency department visits (-8.3% [95% CI, -16.8 to 1.1], -28.5% [95% CI, -62.1 to 34.6], and 11.2% [95% CI, -20.9 to 56.5], respectively). Switching to an HDHP was associated with an increase of $921 (95% CI, $743-$1099) in out-of-pocket costs but no statistically significant difference in total health care costs. Conclusions Among commercially insured patients with chronic cardiovascular disease, switching to an HDHP was not associated with a change in health care use but was associated with an increase in out-of-pocket costs. Although health care use by individuals with chronic cardiovascular disease may not be sensitive to higher cost sharing associated with HDHP enrollment, there may be a significant increase in patients' financial burden.

Identifiants

pubmed: 37750565
doi: 10.1161/JAHA.123.030730
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e030730

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL153772
Pays : United States

Auteurs

Ravi Gupta (R)

Division of General Internal Medicine Johns Hopkins University School of Medicine Baltimore MD.
Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore MD.
Hopkins Business of Health Initiative, Johns Hopkins University Baltimore MD.

Lin Yang (L)

Leonard Davis Institute of Health Economics, University of Pennsylvania Philadelphia PA.
Center for Cardiovascular Outcomes, Quality and Evaluative Research Center University of Pennsylvania Philadelphia PA.

Jennifer Lewey (J)

Leonard Davis Institute of Health Economics, University of Pennsylvania Philadelphia PA.
Center for Cardiovascular Outcomes, Quality and Evaluative Research Center University of Pennsylvania Philadelphia PA.
Division of Cardiovascular Medicine, Perelman School of Medicine University of Pennsylvania Philadelphia PA.

Amol S Navathe (AS)

Leonard Davis Institute of Health Economics, University of Pennsylvania Philadelphia PA.
Division of General Internal Medicine, Perelman School of Medicine University of Pennsylvania PA Philadelphia.
Corporal Michael J. Crescenz Veterans Affairs Medical Center PA Philadelphia.
Department of Medical Ethics and Health Policy, Perelman School of Medicine University of Pennsylvania Philadelphia PA.

Peter W Groeneveld (PW)

Leonard Davis Institute of Health Economics, University of Pennsylvania Philadelphia PA.
Center for Cardiovascular Outcomes, Quality and Evaluative Research Center University of Pennsylvania Philadelphia PA.
Division of General Internal Medicine, Perelman School of Medicine University of Pennsylvania PA Philadelphia.
Corporal Michael J. Crescenz Veterans Affairs Medical Center PA Philadelphia.

Sameed Ahmed M Khatana (SAM)

Leonard Davis Institute of Health Economics, University of Pennsylvania Philadelphia PA.
Center for Cardiovascular Outcomes, Quality and Evaluative Research Center University of Pennsylvania Philadelphia PA.
Division of Cardiovascular Medicine, Perelman School of Medicine University of Pennsylvania Philadelphia PA.
Corporal Michael J. Crescenz Veterans Affairs Medical Center PA Philadelphia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH